Start Alliance Berlin: Digital Health
Start Alliance Berlin: Digital Health
Start Alliance Berlin: Digital Health is a two-week program taking place in November 2018 which is intended to help startups from BEIJING, DUBAI, NEW YORK, LONDON, PARIS, SHANGHAI, TEL AVIV, VIENNA and WARSAW to expand their business to Germany via BERLIN. In this edition the program will focus on Digital Health and related topics.

Diagnostics Accelerator
Diagnostics Accelerator
Philanthropist Bill Gates and the Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder have announced a new initiative, Diagnostics Accelerator, to develop novel biomarkers for the early detection of Alzheimer's disease and related dementias.

CernerCerner has announced the plans to significantly grow its Dublin hub for research and development. Working with the support of the Irish Government through IDA Ireland, will be created 50 new roles focused on R&D and the improvement of data intelligence and population health management for the European clients.

The European Data Protection Supervisor (EDPS), in partnership with the Data Protection Authorities of Austria, Ireland and Schleswig-Holstein and supported by the Internet Privacy Engineering Network (IPEN), is pleased to announce the launch of the EDPS-IPEN Privacy by Design contest for mobile Health (mHealth) applications.

PatientrackNHS professionals at a North West trust have been shortlisted for the prestigious national Patient Safety Awards, following important work around rapid response for deteriorating patients. The team at St Helens and Knowsley Teaching Hospitals NHS Trust innovated with their Patientrack electronic observations system to tackle a major cause of complications for patients on intravenous fluids and electrolytes.

FujitsuThe University of Tokyo's Research Center for Advanced Science and Technology (RCAST), Fujitsu Limited, and Kowa Company Ltd. today announced that using IT-based drug discovery technologies, which entails computer-based virtual design and evaluation, they have successfully created new small molecule compounds that can inhibit cancer-causing "target proteins," and that demonstrate promise against cancers that have shown resistance to existing drugs.

LexmarkLexmark, a global imaging solutions leader, today announced a partnership with NHS Shared Business Services (NHS SBS) to enable the public sector to utilise Lexmark technology to support their aim of meeting paperless and digital targets, whilst delivering savings, efficiencies and improving patient care. The framework allows Lexmark to integrate hardware and software platforms to drive interoperability and 'paperlight' working environments within the Public Sector.

More Digital Health News ...

Page 61 of 226